Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association.
選擇性圍手術管理成人使用glucagon-like peptide-1 receptor agonists、glucose-dependent insulinotropic peptide agonists及sodium-glucose cotransporter-2 inhibitors的共識聲明：來自麻醉醫師協會、英國臨床糖尿病醫師協會、英國肥胖與代謝外科學會、圍手術期護理中心、英國住院病人糖尿病協會、皇家麻醉醫學院、肥胖與減重麻醉學會及英國臨床藥學協會的共識聲明。
Anaesthesia 2025-01-09
Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications.
過去二十年開發的降糖藥及其圍手術期的影響。
Pharmaceuticals (Basel) 2025-01-25
Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms.
GLP-1 受體激動劑和 SGLT2 抑制劑的圍手術及圍程序管理：敘述性回顧及 STOP-GAP 和 STOP DKA-2 演算法。
Curr Med Res Opin 2025-01-28
Perioperative euglycemic DKA: The YIN and YANG of sodium-glucose cotransporter 2 inhibitors.
圍手術期正常血糖性酮症酸中毒：鈉-葡萄糖共轉運蛋白 2 抑制劑的陰與陽。
J Anaesthesiol Clin Pharmacol 2025-03-03
A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia.
深度鎮靜或全身麻醉前的胰高血糖素樣肽-1受體激動劑敘述性綜述。
J Anesth Analg Crit Care 2025-03-29